Welcome to

United Therapeutics Global Medical Affairs

This website is a resource intended for U.S. healthcare professionals only. This site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. United Therapeutics does not provide medical advice. It is the healthcare professional’s responsibility to use independent clinical judgment when making clinical decisions for individual patients.

This website may include information that has not been approved by the U.S. Food and Drug Administration. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling.

Are you a U.S. Healthcare professional?

You are now leaving the UnitherMedAffairs.com website.

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to UnitherMedAffairs.com.

CONTINUE

Cardiopulmonary

A Patient Registry of the Real-world Use of Oral Treprostinil

For more information visit: ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH-Specific Background Therapy in Subjects With WHO Group 1 PAH

For more information visit: ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy

For more information visit: ClinicalTrials.gov

A 16-Week, Multicenter, Open-label Study of Parenteral Treprostinil Induction Followed by Oral Treprostinil Optimization in Subjects With Pulmonary Arterial Hypertension

For more information visit: ClinicalTrials.gov

A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

For more information visit: ClinicalTrials.gov

An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Treprostinil Inhalation Solution

For more information visit: ClinicalTrials.gov